STAT+: In earnings call, Hims CEO addresses scrutiny of GLP-1 compounding
STAT [Unofficial]
February 24, 2026
In earnings call, Hims & Hers CEO Andrew Dudum addressed the increased scrutiny on compounded GLP-1s and its impact on the business’s bottom line.
Discussion in the ATmosphere